Abzena
Deborah Evrard has a diverse work experience. Deborah started their career at Eli Lilly in 1994 as a Senior Organic Chemist, where they contributed to the discovery of novel therapeutic agents for diabetes and obesity. Deborah then joined Pfizer in 1998 as a Principal Research Scientist, where they led structure-activity relationship studies and advanced drug candidates for the treatment of depression and chronic pain. In 2012, Deborah founded and managed their own company, D & B Assets, LLC, which involved researching distressed real estate properties and overseeing investments. Since 2015, they have been working as a Principal Scientist at Abzena.
Deborah Evrard holds a Ph.D. in Synthetic Organic Chemistry from Harvard University (1988-1994) and a B.S. in Chemistry from the University of Louisville (1981-1985).
This person is not in any offices
Abzena
1 followers
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.